Dr. Melissa Moore, global messenger RNA (mRNA) expert and chief scientific officer of Moderna’s mRNA research platform, joins Dr. Diane Hayes, InCrowd co-founder and board member, for Exploring What Physicians Know and Don’t Know About Nucleic Acid-Based Medicines, a webinar examining the emerging therapy area, medications in the field, and analysis of recent InCrowd prescriber research.
Key learnings:
- A high-level understanding of the emerging class of therapeutics based on molecular biology approaches to altering gene expression by targeting nucleic acids (DNA and RNA)
- Prescriber awareness of nucleic acid-based medicines
- Insight across a variety of specialists from academic medical centers, as well as other practice settings
- Prescriber perceptions of the potential impact of nucleic acid-based medicines
Who should watch:
- Anyone interested in nucleic acid-based medicines
- Healthcare and life science marketers, market insights, research, new business, and commercialization professionals
- Healthcare and hospital administrators
- Physicians and biologists interested or involved in nucleic acid-based medicines
- Payors
- Pharmacists
- Those interested in therapeutic innovation
